BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 29499280)

  • 1. Lipoxin A4 may attenuate the progression of obesity-related glomerulopathy by inhibiting NF-κB and ERK/p38 MAPK-dependent inflammation.
    Guo YP; Jiang HK; Jiang H; Tian HY; Li L
    Life Sci; 2018 Apr; 198():112-118. PubMed ID: 29499280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of liraglutide on glomerular podocytes in obese mice by inhibiting the inflammatory factor TNF-α-mediated NF-κB and MAPK pathway.
    Ye Y; Zhong X; Li N; Pan T
    Obes Res Clin Pract; 2019; 13(4):385-390. PubMed ID: 30952571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoxin A4 attenuates radicular pain possibly by inhibiting spinal ERK, JNK and NF-κB/p65 and cytokine signals, but not p38, in a rat model of non-compressive lumbar disc herniation.
    Miao GS; Liu ZH; Wei SX; Luo JG; Fu ZJ; Sun T
    Neuroscience; 2015 Aug; 300():10-8. PubMed ID: 25943485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoxin A4 inhibits proliferation and inflammatory cytokine/chemokine production of human epidermal keratinocytes associated with the ERK1/2 and NF-κB pathways.
    Hu F; Liu XX; Wang X; Alashkar M; Zhang S; Xu JT; Zhong XL; He MW; Feng AP; Chen HX
    J Dermatol Sci; 2015 Jun; 78(3):181-8. PubMed ID: 25847211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoxin A4 attenuation of endothelial inflammation response mimicking pancreatitis-induced lung injury.
    Lv W; Lv C; Yu S; Yang Y; Kong H; Xie J; Sun H; Andersson R; Xu D; Chen B; Zhou M
    Exp Biol Med (Maywood); 2013 Dec; 238(12):1388-95. PubMed ID: 24000382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoxin A4 suppresses osteoclastogenesis in RAW264.7 cells and prevents ovariectomy-induced bone loss.
    Liu C; Guan H; Cai C; Li F; Xiao J
    Exp Cell Res; 2017 Mar; 352(2):293-303. PubMed ID: 28209487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation.
    Kure I; Nishiumi S; Nishitani Y; Tanoue T; Ishida T; Mizuno M; Fujita T; Kutsumi H; Arita M; Azuma T; Yoshida M
    J Pharmacol Exp Ther; 2010 Feb; 332(2):541-8. PubMed ID: 19846590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoxin A4 Reduces Inflammation Through Formyl Peptide Receptor 2/p38 MAPK Signaling Pathway in Subarachnoid Hemorrhage Rats.
    Guo Z; Hu Q; Xu L; Guo ZN; Ou Y; He Y; Yin C; Sun X; Tang J; Zhang JH
    Stroke; 2016 Feb; 47(2):490-7. PubMed ID: 26732571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoxin A4 attenuates brain damage and downregulates the production of pro-inflammatory cytokines and phosphorylated mitogen-activated protein kinases in a mouse model of traumatic brain injury.
    Luo CL; Li QQ; Chen XP; Zhang XM; Li LL; Li BX; Zhao ZQ; Tao LY
    Brain Res; 2013 Mar; 1502():1-10. PubMed ID: 23370001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipoxin A4 inhibits the invasion and migration of endometrial stromal cells by down-regulating NF-κB signaling-mediated autophagy].
    Li YH; Geng YY; Liu L; Chen CY; Gao Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Aug; 53(8):547-553. PubMed ID: 30138965
    [No Abstract]   [Full Text] [Related]  

  • 11. Coptidis Rhizoma inhibits NLRP3 inflammasome activation and alleviates renal damage in early obesity-related glomerulopathy.
    Ren Y; Wang D; Lu F; Zou X; Xu L; Wang K; Huang W; Su H; Zhang C; Gao Y; Dong H
    Phytomedicine; 2018 Oct; 49():52-65. PubMed ID: 30217262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoxin A4 Methyl Ester Reduces Early Brain Injury by Inhibition of the Nuclear Factor Kappa B (NF-κB)-Dependent Matrix Metallopeptidase 9 (MMP-9) Pathway in a Rat Model of Intracerebral Hemorrhage.
    Song Y; Yang Y; Cui Y; Gao J; Wang K; Cui J
    Med Sci Monit; 2019 Mar; 25():1838-1847. PubMed ID: 30855024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptospiral membrane proteins stimulate pro-inflammatory chemokines secretion by renal tubule epithelial cells through toll-like receptor 2 and p38 mitogen activated protein kinase.
    Hung CC; Chang CT; Tian YC; Wu MS; Yu CC; Pan MJ; Vandewalle A; Yang CW
    Nephrol Dial Transplant; 2006 Apr; 21(4):898-910. PubMed ID: 16339163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoxin A4-Mediated p38 MAPK Signaling Pathway Protects Mice Against Collagen-Induced Arthritis.
    Li J; Sun Q; Zheng C; Bai C; Liu C; Zhao X; Deng P; Chai L; Jia Y
    Biochem Genet; 2021 Feb; 59(1):346-365. PubMed ID: 33221976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic effects of lipoxin A
    Yang Y; Wang Y; Kong Y; Zhang X; Zhang H; Gang Y; Bai L
    Mol Immunol; 2018 Nov; 103():35-45. PubMed ID: 30196232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney.
    Ma FY; Tesch GH; Ozols E; Xie M; Schneider MD; Nikolic-Paterson DJ
    Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1410-21. PubMed ID: 21367917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-Dependent Protective and Pro-Resolving Effects of FPR2 Agonists on Lipopolysaccharide-Exposed Microglia Cells Involve Inhibition of NF-κB and MAPKs Pathways.
    Tylek K; Trojan E; Leśkiewicz M; Regulska M; Bryniarska N; Curzytek K; Lacivita E; Leopoldo M; Basta-Kaim A
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 14-3-3γ Regulates Lipopolysaccharide-Induced Inflammatory Responses and Lactation in Dairy Cow Mammary Epithelial Cells by Inhibiting NF-κB and MAPKs and Up-Regulating mTOR Signaling.
    Liu L; Lin Y; Liu L; Bian Y; Zhang L; Gao X; Li Q
    Int J Mol Sci; 2015 Jul; 16(7):16622-41. PubMed ID: 26204835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoxin A4 mitigates experimental autoimmune myocarditis by regulating inflammatory response, NF-κB and PI3K/Akt signaling pathway in mice.
    Shi Y; Pan H; Zhang HZ; Zhao XY; Jin J; Wang HY
    Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1850-1859. PubMed ID: 28485793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoxin A
    Zhang T; Hao H; Zhou ZQ; Zeng T; Zhang JM; Zhou XY
    Prostaglandins Other Lipid Mediat; 2020 Feb; 146():106380. PubMed ID: 31698141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.